<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE297nnn/GSE297724/</Other></files><type>primary</type></body><statusCodeValue>200</statusCodeValue><statusCode>OK</statusCode></file_versions><scores/><additional><omics_type>Genomics</omics_type><species>Mus musculus</species><gds_type>Genome binding/occupancy profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297724</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>FOXK1 regulates effector T cell differentiation and function by repressing autophagy programs via the Akt-mTOR signaling pathway [Foxk1_ChIP-seq]</name><description>Upon T Cell Receptor (TCR) engagement, the Akt-mTOR signaling cascade initiates downstream events that orchestrate metabolic reprogramming in T cells through the coordinated activation of distinct transcription factors (TFs). Here, we demonstrate that Foxk1 is an integrating component of the Akt-mTOR signaling program, mediating T cell activation and differentiation. Foxk1 deficiency leads to impaired effector functions in both CD4⁺ and CD8⁺ T cells, associated with defects in metabolic reprogramming. We demonstrate that this is due to Foxk1’s ability to repress autophagy-related genes within hours following TCR stimulation. Conversely, overexpression or enforced nuclear localization of Foxk1 enhances effector-like phenotype of T cells, leading to better anti-tumor responses. Our results demonstrate the central role played by Foxk1 in initiating T cell activation and in shaping their differentiation trajectory.</description><dates><publication>2026/09/01</publication></dates><accession>GSE297724</accession><cross_references><GSM>GSM8997450</GSM><GSM>GSM8997449</GSM><GPL>30172</GPL><GSE>297724</GSE><taxon>Mus musculus</taxon></cross_references></HashMap>